PROQR THERAPEUTICS EO-04 (0PQ) — Defensive Interval Ratio

Latest as of December 2025: 38 days

PROQR THERAPEUTICS EO-04 (0PQ) has a Defensive Interval Ratio of 38 days as of December 2025. Defensive assets of €3.36 Million (cash €-, short-term investments €-, receivables €3.36 Million) cover 38 days of daily cash needs of €88.88K/day. Check PROQR THERAPEUTICS EO-04 tangible equity quality to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

38 days
Days of operational coverage

Defensive Assets

€3.36 Million
Cash + ST Investments + Receivables

Daily Cash Need

€88.88K
Current Liabilities ÷ 365

Current Liabilities

€32.44 Million
EUR

PROQR THERAPEUTICS EO-04 Defensive Interval Ratio (2024–2025)

This chart shows how PROQR THERAPEUTICS EO-04's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 38 days, meaning defensive assets of €3.36 Million can fund 38 days of operations without new revenue. Also explore net asset momentum of PROQR THERAPEUTICS EO-04 to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for PROQR THERAPEUTICS EO-04 (2024–2025)

The table below presents the year-by-year Defensive Interval Ratio for PROQR THERAPEUTICS EO-04 from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see PROQR THERAPEUTICS EO-04 (0PQ) total market value.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 38 days €3.36 Million €88.88K/day €- €- ▲ +38 days
2024 0 days €0.00 €106.58K/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)